Pfizer, INC.
Biopharmaceuticals manufacturer
Based in NY
🤖
AI Overview
With $750K in lobbying spend across 11 quarterly filings, Pfizer, INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2021 to 2023.
$750K
Total Spend
3
Years Active
1
Firms Hired
5
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $110K |
| 2022 | $320K |
| 2023 | $320K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Trade, Taxation, Health Issues, Medicare/Medicaid
- •General health care policy and biopharmaceutical manufacturing issues.
Related Analysis
Related Investigations
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.